Catalogo dei prodotti della ricerca

MAZZUCCONI, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.938
EU - Europa 3.064
AS - Asia 1.893
SA - Sud America 190
AF - Africa 36
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.846
SG - Singapore 1.052
IT - Italia 1.028
SE - Svezia 637
IN - India 484
UA - Ucraina 336
CN - Cina 301
FI - Finlandia 241
RU - Federazione Russa 239
DE - Germania 171
BR - Brasile 146
RO - Romania 87
CA - Canada 70
GB - Regno Unito 63
BG - Bulgaria 46
IE - Irlanda 43
BE - Belgio 35
AR - Argentina 34
AT - Austria 29
NL - Olanda 27
GR - Grecia 24
FR - Francia 17
MX - Messico 14
ZA - Sudafrica 13
CH - Svizzera 9
SC - Seychelles 7
TG - Togo 7
VN - Vietnam 7
AU - Australia 6
DK - Danimarca 6
IR - Iran 5
AZ - Azerbaigian 4
HK - Hong Kong 4
PA - Panama 4
TR - Turchia 4
BD - Bangladesh 3
CZ - Repubblica Ceca 3
EU - Europa 3
HR - Croazia 3
ID - Indonesia 3
IL - Israele 3
IQ - Iraq 3
LT - Lituania 3
PE - Perù 3
PL - Polonia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EC - Ecuador 2
ES - Italia 2
JM - Giamaica 2
JO - Giordania 2
JP - Giappone 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MT - Malta 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TH - Thailandia 1
UY - Uruguay 1
Totale 13.131
Salva come PNG Salva come JPEG
Città #
Fairfield 1.103
Woodbridge 684
Singapore 539
Chandler 528
Ann Arbor 494
Ashburn 492
Houston 440
Seattle 411
Wilmington 390
Cambridge 360
Princeton 351
San Paolo di Civitate 315
Plano 270
Beijing 198
Rome 198
Lawrence 177
Boston 169
Santa Clara 142
Des Moines 137
Millbury 117
Jacksonville 114
San Diego 94
Andover 69
Norwalk 55
Moscow 54
Toronto 47
Sofia 46
Dublin 43
Dearborn 40
Brussels 35
Milan 35
Falkenstein 34
Mannheim 31
Yubileyny 27
Federal 24
San Mateo 24
Southend 24
Bremen 23
Council Bluffs 23
Boardman 20
New York 20
Bühl 18
Cosenza 18
Helsinki 16
Ottawa 15
Nuremberg 14
Vienna 14
Hefei 12
London 12
Nanjing 12
Bologna 11
Florence 11
São Paulo 10
Falls Church 9
Kunming 9
Los Angeles 9
Buffalo 8
Muizenberg 8
Lomé 7
Provo 7
Dallas 6
Eboli 6
Ho Chi Minh City 6
Indiana 6
Pavia 6
Trento 6
Belo Horizonte 5
Catania 5
Curitiba 5
Guangzhou 5
Nanchang 5
Napoli 5
Padova 5
Philadelphia 5
Redwood City 5
Stockholm 5
Verona 5
Baku 4
Bari 4
Bern 4
Brescia 4
Chicago 4
Fremont 4
Ghisalba 4
Hong Kong 4
Laurel 4
Redmond 4
Richardson 4
Rio de Janeiro 4
Salerno 4
Turin 4
Zurich 4
Chapel Hill 3
Coominya 3
Desio 3
Fort Worth 3
Frankfurt am Main 3
Jakarta 3
Jeddah 3
Jinan 3
Totale 8.792
Salva come PNG Salva come JPEG
Nome #
LA COAGULAZIONE INTRAVASCOLARE DISSEMINATA (DIC) IN OSTETRICIA E GINECOLOGIA 443
Piastrinopenia immune HIV correlata: descrizione di 20 casi. 172
Efficacy of rituximab treatment in postpartum acquired haemophilia A. 111
ANTITHROMBIN III INFUSION SUPPRESSES THE HYPERCOAGULABLE STATE IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA PATIENTS TREATED WITH A LOW-DOSE OF ESCHERICHIA COLI L-ASPARAGINASE. A GIMEMA STUDY 103
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience 95
Carrier detection in factor VII congenital deficiency. 94
Acquired haemophilia in severe pelvic endometriosis: a new association? 93
Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: A controlled study 92
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome 90
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey 87
Maternal thrombophilia and adverse pregnancy outcome: a case-control study 87
Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone 85
Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G > A (FVII Lazio) mutation 84
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group 84
A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen. 84
Factor VII deficiency: Immunological characterization of genetic variants and detection of carriers 83
Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study 83
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: An index of different clinical severity of the 2 coagulation disorders 82
Thrombotic thrombocytopenic purpura in the first trimester and successful pregnancy 80
A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers. 77
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study 76
Factor VII activity and antigen in haemophilia B variants. 76
Acquired FXIII deficiency and AL amyloidosis: A case of a rare association 76
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 74
COAGULATION STUDY IN PATIENTS WHO HAD UNDERGONE SURGERY FOR MENINGIOMA 73
EVIDENCE OF A HYPERCOAGULABLE STATE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH LOW-DOSE E. COLI L-ASPARAGINASE: A GIMEMA STUDY 72
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia. 72
Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors? 71
PROGRESSION IN AIDS AMONG ITALIAN HIV-SEROPOSITIVE HAEMOPHILIACS 71
ACQUIRED INHIBITOR AGAINST FACTOR IX IN A CHILD: SUCCESSFUL TREATMENT WITH HIGH-DOSE IMMUNOGLOBULINE AND DEXAMETHASONE 70
Patients with type 3 severe von Willebrand Disease are not protected against atherosclerosis. Results from a multicenter study group. 70
Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms 70
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case. 70
AUTOIMMUNITY IN MULTIPLE SCLEROSIS: STUDY A WIDE SPECTRUM OF AUTOANTIBODIES 70
SURVIVAL AFTER AIDS AMONG ITALIAN HAEMOPHILIACS WITH HIV INFECTION 69
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients 69
AUTOIMMUNE THROMBOCYTOPENIC PURPURA :MATERNAL AND FETAL DISEASE 69
AUTOIMMUNE THROMBOCYTOPENIC PURPURA IN PREGNANCY: MATERNAL RISK FACTORS PREDICTIVE OF NEONATAL THROMBOCYTOPENIA 69
Alte dosi di ARA-C + Idarubicina nel trattamento della leucemia linfoide acuta in fase avanzata 68
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 68
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. 68
Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score. 67
A long-term study of young patients with essential Thrombocythemia treated with anagrelide. 67
CLINICAL FACTORS ASSOCIATED WITH PROGRESSION TO AIDS IN THE ITALIAN COHORT OF HIV-POSITIVE HEMOPHILIACS 67
ASCORBIC ACID FOR THE TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIC PURPURA 66
Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay. 66
Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety. 65
A Case Of Thrombosis In Congenital Afibrinogenemia: A Physiopathologic And Management Dilemma 65
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. 65
Performance of recalibrated refacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated refacto (B-domain deleted recombinant factor VIII) 64
Inherited thrombophilia in patients with thrombotic thrombocytopenic purpura 64
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. 64
RECOMBINANT ALPHA 2b INTERFERON IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA 63
Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia (pITP): Investigating Differences Amongst Newly Diagnosed, Persistent and Chronic Pitp Patients 63
CLONAL HEMOPOIESIS AND RISK OF THROMBOSIS IN YOUNG FEMALE PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA 63
Comparison of the recovery and half-life of a high-purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study Group. 62
Factor VII activity and cross reacting material in normal individuals. 62
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 62
CARRIER DETECTION AND PRENATAL DIAGNOSIS IN HEMOPHILIA A AND B 62
MARKERS OF PROCOAGULANT IMBALANCE IN PATIENTS WITH INHERITED TRHOMBOPHILIC SYNDROME 61
Prevalence of allo-immunization anti-HLA and anti-integrin alpha IIb beta 3 in Glanzmann thromboasthenia patients 60
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results 60
Application of Global Coagulation Assays in Hemophilia B Patients to Evaluate the Hemostatic Potential in Baseline Conditions 60
Application of global coagulation assays in Hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 60
Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT). 60
Treatment of idiopathic thrombocytopenic purpura (ITP): results of a multicentric protocol. 59
Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy 59
PIPOBROMAN THERAPY OF ESSENTIAL THROMBOCYTHEMIA 58
HIGH DOSE INTRAVENOUS GAMMAGLOBULIN (HDIVG): THERAPY OF REFRACTORY ITP IN ADULTS AND CHILDREN 58
ACTOR VII CONGENITAL DEFICIENCY: CLINICAL PICTURE AND CLASSIFICATION OF THE VARIANTS 58
Treatment of congenital factor VII deficiency with a new concentrate 58
Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: Results of a retrospective study from a single centre 58
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis 58
Risultati di uno studio randomizzato con prednisone a basse o alte dosi in bambini e adolescenti con porpora trombocitopenia idiopatica (PTI). [RESULTS OF A RANDOMIZED TRIAL WITH PREDNISONE AT LOW OR HIGH DOSES IN CHILDREN AND ADOLESCENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA] 58
Decisional flow with a score system to start platelet-lowering treatment in patients with essential thrombocythemia (ET): Long-term results 58
HYPERCOAGULABILITY DURING INDUCTION THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA IS OF SCARCE CLINICAL RELEVANCE 57
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases 57
Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma. 57
Anagrelide treatment and cardiovascular evaluation in 130 patients with essential thrombocythemia (ET): Preliminary report of the Registro Italiano Trombocitemia (RIT). 57
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 57
DETECTION OF DRUG-DEPENDENT IgG ANTIBODIES WITH ANTIPLATELET ACTIVITY BY THE ANTIGLOBULIN CONSUMPTION ASSAY 57
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy 57
Risk Factors for Thrombosis Vary According to Age in Patients with Essential Thrombocythemia: a Retrospective Analysis of 1090 Patients from the "Gruppo Laziale SMPC Ph Negative 56
A case of thrombosis in congenital afibrinogenemia patient: a physiopathologic and management dilemma 56
Application of global coagulation assays in hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 56
Efficacy and safety of antithrombotic prophylactic therapy with low-molecular weight heparin (LMWH) after orthopedic surgery in hemophilia patients 55
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. 55
HETEROGENEITY OF TYPE 1 VON WILLWBRAND DISEASE: EVIDENCE FOR A SUBGROUP WITH AN ABNORMAL VON WILLEBRAND FACTOR 55
A prospective randomized study of rituximab and dexamethasone vs dexamethasone alone in ITP 54
Tailored versus standard dose prophylaxis in children with hemophilia A. 54
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 54
Long-term evaluation of 164 patients with essential thrombocythaemia treated with pipobroman: occurrence of leukaemic evolution 54
ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DESCRIPTION AND ANALYSIS OF LONG TERM SURVIVORS. A RETROSPECTIVE STUDY 54
Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity. 53
Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family. 53
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 53
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study 53
Thrombosis History and Relationship with Low Thrombocytosis, Leukocytosis, and Jak2 V617F Mutation In A Cohort of 977 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia(RIT) 52
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. 52
Efficacy of low dose prednisone plus aspirin in preventing spontaneous abortions and/or fetal deaths due to antiphospholipid antibodies: Results of a pilot study 52
Totale 7.170
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020703 0 0 0 0 0 0 0 0 257 225 123 98
2020/2021717 93 101 38 80 19 48 22 89 81 64 67 15
2021/20222.660 13 149 211 153 385 89 56 250 162 241 344 607
2022/20232.560 585 727 87 196 182 335 56 112 172 18 72 18
2023/2024793 56 121 29 50 58 61 17 17 3 127 105 149
2024/20251.786 86 210 117 83 163 158 223 162 584 0 0 0
Totale 13.474